{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T09:55:28Z","timestamp":1720518928351},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,6,27]]},"DOI":"10.1001\/jama.2023.9929","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T15:01:16Z","timestamp":1686150076000},"page":"2119","source":"Crossref","is-referenced-by-count":1,"title":["Extended-Release Buprenorphine Receives FDA Green Light"],"prefix":"10.1001","volume":"329","author":[{"given":"Emily","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2806026\/jama_harris_2023_ib_230178_1687798739.92868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T15:44:47Z","timestamp":1687880687000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2806026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":0,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,6,27]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.9929","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,27]]}}}